Adverum Biotechnologies
ADVM
ADVM
110 hedge funds and large institutions have $155M invested in Adverum Biotechnologies in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 34 increasing their positions, 39 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 39
35% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 20
45% less capital invested
Capital invested by funds: $279M → $155M (-$125M)
Holders
110
Holding in Top 10
2
Calls
$5.78M
Puts
$2.05M
Top Buyers
| 1 | +$1.84M | |
| 2 | +$1.72M | |
| 3 | +$1.66M | |
| 4 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$1.64M |
| 5 |
Morgan Stanley
New York
|
+$1.08M |
Top Sellers
| 1 | -$16.3M | |
| 2 | -$9.89M | |
| 3 | -$1.47M | |
| 4 |
BlackRock
New York
|
-$1.19M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.16M |